CME Sues CFTC Over Bitcoin Perpetual Futures Approval for Kalshi and Coinbase

CME Group filed a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC) and CFTC Chairman Michael Sellig on 18일(현지시간), challenging the regulator's approval of Bitcoin perpetual futures products offered by Kalshi and Coinbase, according to Reuters. CME argues the CFTC's decision to classify these products as futures contracts contradicts the agency's prior interpretation under the Dodd-Frank Act, which would categorize them as swap contracts. The lawsuit reflects regulatory uncertainty over cryptocurrency derivative classifications as traditional exchanges face competition from crypto-native platforms.

CME Challenges Dodd-Frank Act Classification

CME Group contends in its complaint that the Bitcoin perpetual futures products approved for Kalshi and Coinbase constitute swap contracts under the Dodd-Frank Act. The exchange operator states the CFTC previously interpreted such instruments as swaps, making the agency's reclassification as futures contracts an arbitrary and capricious action. CME further argues in the filing that the CFTC's approval decision could result in anti-competitive effects in the derivatives market.

Stock Prices Decline Following CFTC Decision

CME Group and Intercontinental Exchange (ICE), the parent company of the New York Stock Exchange, experienced stock price declines following the CFTC's approval decision. Reuters analyzed the market movement as reflecting investor concerns about competitive threats posed by the newly approved products.

CFTC Official Responds to CME Lawsuit

A CFTC official told Reuters that CME chose to pursue legal action against the government's innovation-promoting policies rather than compete in the marketplace. The official stated that incumbent firms fear the future and do not want fair competition.

FAQ

What did CME Group file on 18일(현지시간)?

CME Group filed a lawsuit against the CFTC and CFTC Chairman Michael Sellig on 18일(현지시간), challenging the approval of Bitcoin perpetual futures for Kalshi and Coinbase.

Why does CME argue the CFTC approval was arbitrary?

CME argues the products are swap contracts under the Dodd-Frank Act and the CFTC previously interpreted them as such, making the reclassification as futures contracts arbitrary and capricious.

How did the CFTC decision affect CME and ICE stock prices?

CME Group and Intercontinental Exchange stock prices declined after the CFTC approval, which Reuters analyzed as investor concerns about competitive threats.